Hikma Pharmaceuticals PLC (HIK) — Cash Flow Reinvestment Rate
Hikma Pharmaceuticals PLC (HIK) has a Cash Flow Reinvestment Rate of 0.42x as of June 2025, reinvesting GBX68.00 Million (capex GBX68.00 Million ) from operating cash flow of GBX161.00 Million. Check cash flow quality index of Hikma Pharmaceuticals PLC to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hikma Pharmaceuticals PLC Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Hikma Pharmaceuticals PLC across 23 annual periods. Explore Hikma Pharmaceuticals PLC long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Hikma Pharmaceuticals PLC (2002–2024)
Year-by-year capital reinvestment analysis for Hikma Pharmaceuticals PLC. For live market cap and broader valuation context, see market cap of Hikma Pharmaceuticals PLC.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.97x | GBX546.00 Million | GBX564.00 Million | GBX165.00 Million | ▲ +17.3% |
| 2023 | 0.83x | GBX502.00 Million | GBX608.00 Million | GBX169.00 Million | ▼ -47.4% |
| 2022 | 1.57x | GBX832.00 Million | GBX530.00 Million | GBX225.00 Million | ▲ +114.5% |
| 2021 | 0.73x | GBX467.00 Million | GBX638.00 Million | GBX229.00 Million | ▲ +49.6% |
| 2020 | 0.49x | GBX227.00 Million | GBX464.00 Million | GBX224.00 Million | ▲ +19.0% |
| 2019 | 0.41x | GBX194.00 Million | GBX472.00 Million | GBX186.00 Million | ▲ +59.2% |
| 2018 | 0.26x | GBX111.00 Million | GBX430.00 Million | GBX107.00 Million | ▼ -0.6% |
| 2017 | 0.26x | GBX115.00 Million | GBX443.00 Million | GBX107.00 Million | ▼ -90.7% |
| 2016 | 2.79x | GBX817.00 Million | GBX293.00 Million | GBX122.00 Million | ▲ +890.8% |
| 2015 | 0.28x | GBX103.00 Million | GBX366.00 Million | GBX82.00 Million | ▲ +6.8% |
| 2014 | 0.26x | GBX112.00 Million | GBX425.00 Million | GBX91.00 Million | ▲ +5.7% |
| 2013 | 0.25x | GBX84.00 Million | GBX337.00 Million | GBX59.00 Million | ▼ -49.7% |
| 2012 | 0.50x | GBX90.19 Million | GBX182.16 Million | GBX90.19 Million | ▼ -34.8% |
| 2011 | 0.76x | GBX78.00 Million | GBX102.64 Million | GBX78.00 Million | ▲ +98.3% |
| 2010 | 0.38x | GBX53.20 Million | GBX138.79 Million | GBX53.20 Million | ▲ +0.2% |
| 2009 | 0.38x | GBX40.38 Million | GBX105.52 Million | GBX40.38 Million | ▼ -66.2% |
| 2008 | 1.13x | GBX65.52 Million | GBX57.87 Million | GBX65.52 Million | ▼ -11.2% |
| 2007 | 1.28x | GBX54.99 Million | GBX43.12 Million | GBX54.99 Million | ▼ -27.1% |
| 2006 | 1.75x | GBX52.44 Million | GBX29.99 Million | GBX52.44 Million | ▲ +138.5% |
| 2005 | 0.73x | GBX23.98 Million | GBX32.71 Million | GBX23.98 Million | ▲ +12.9% |
| 2004 | 0.65x | GBX21.33 Million | GBX32.84 Million | GBX21.33 Million | — |
| 2003 | 0.00x | GBX0.00 | GBX18.35 Million | GBX0.00 | — |
| 2002 | 0.00x | GBX0.00 | GBX14.35 Million | GBX0.00 | — |